3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2767
Carcinoma, Non-Small-Cell Lung
2265
Prostatic Neoplasms
1427
Colorectal Neoplasms
1295
Neoplasms
1260
Multiple Myeloma
1086
Lung Neoplasms
1049
Neoplasm Metastasis
995
Leukemia, Myeloid, Acute
985
Lymphoma
900
Melanoma
864
Pancreatic Neoplasms
818
Ovarian Neoplasms
805
Carcinoma, Hepatocellular
782
Stomach Neoplasms
753
Recurrence
753
Leukemia
733
Lymphoma, Non-Hodgkin
684
Leukemia, Lymphocytic, Chronic, B-Cell
665
Squamous Cell Carcinoma of Head and Neck
618
Lymphoma, Large B-Cell, Diffuse
617
Precursor Cell Lymphoblastic Leukemia-Lymphoma
605
Head and Neck Neoplasms
598
Brain Neoplasms
593
Carcinoma, Renal Cell
587
Glioblastoma
573
Rectal Neoplasms
565
Sarcoma
523
Myelodysplastic Syndromes
522
Lymphoma, Follicular
516
Interventions
ribociclib
1
Tretinoin
1
Letrozole
1
Goserelin
1
Drug Therapy
1
Chemotherapy, Adjuvant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Interventional
×
HER2 Negative Breast Cancer
×
Clear all
NCT06953882
2026-05-26
SELECT
Yale University
Phase 2
Recruiting
140 enrolled
NCT06731140
2025-11-17
Resilire
Fudan University
Phase 2
Recruiting
10 enrolled